Analyst Ratings for Amylyx Pharmaceuticals inc. (AMLX)
AMLX Rating Summary
AMLX Price Target Summary
- Highest: $53.00 (Citi)
- Lowest: $3.00 (Goldman Sachs)
- Average: $11.21
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$11.21 (+493.3%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
Avg. $ Target:
$11.21 (+493.3%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2024 | Mizuho | Graig Suvannavejh | Downgrade | Neutral (Buy) |
4.00 (32.00) |
3.17 (1.89) |
-40.38% | Details |
| 3/11/2024 | Leerink Partners | Marc Goodman | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
3.36 (1.89) |
-43.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
